Moderna COVID-19 vaccine bivalent was initially punctured on DEC 27, 2022 at 10:00 AM and on DEC 28, 2022 2 doses were given more than 24 hours after the initial vial puncture (9:57AM and 4:11PM); No adverse event; Moderna COVID-19 vaccine bivalent was initially punctured on DEC 27, 2022 at 10:00 AM and on DEC 28, 2022 2 doses were given more than 24 hours after the initial vial puncture (9:57AM and 4:11PM); This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine bivalent was initially punctured on DEC 27, 2022 at 10:00 AM and on DEC 28, 2022 2 doses were given more than 24 hours after the initial vial puncture (9:57AM and 4:11PM)), PRODUCT STORAGE ERROR (Moderna COVID-19 vaccine bivalent was initially punctured on DEC 27, 2022 at 10:00 AM and on DEC 28, 2022 2 doses were given more than 24 hours after the initial vial puncture (9:57AM and 4:11PM)) and NO ADVERSE EVENT (No adverse event) in a 65-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: Pneumococcal 20 vaccine (Had received a pneumococcal 20 vaccine. Expiration date of vaccine was 13-Jan-2023) on 06-Dec-2022. Past adverse reactions to the above products included No adverse event with Pneumococcal 20 vaccine.    On 28-Dec-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .5 milliliter. On 28-Dec-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine bivalent was initially punctured on DEC 27, 2022 at 10:00 AM and on DEC 28, 2022 2 doses were given more than 24 hours after the initial vial puncture (9:57AM and 4:11PM)). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Moderna COVID-19 vaccine bivalent was initially punctured on DEC 27, 2022 at 10:00 AM and on DEC 28, 2022 2 doses were given more than 24 hours after the initial vial puncture (9:57AM and 4:11PM)) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine bivalent was initially punctured on DEC 27, 2022 at 10:00 AM and on DEC 28, 2022 2 doses were given more than 24 hours after the initial vial puncture (9:57AM and 4:11PM)), PRODUCT STORAGE ERROR (Moderna COVID-19 vaccine bivalent was initially punctured on DEC 27, 2022 at 10:00 AM and on DEC 28, 2022 2 doses were given more than 24 hours after the initial vial puncture (9:57AM and 4:11PM)) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine bivalent was initially punctured on DEC 27, 2022 at 10:00 AM and on DEC 28, 2022 2 doses were given more than 24 hours after the initial vial puncture (9:57AM and 4:11PM)) and PRODUCT STORAGE ERROR (Moderna COVID-19 vaccine bivalent was initially punctured on DEC 27, 2022 at 10:00 AM and on DEC 28, 2022 2 doses were given more than 24 hours after the initial vial puncture (9:57AM and 4:11PM)).    Concomitant medications were not reported.  It was reported that a vial of the Moderna COVID-19 vaccine bivalent was initially punctured on 27-Dec-2022 at 10:00 AM, where 3 doses were administered. Yesterday on 28-Dec-2022, 2 doses were given more than 24 hours after the initial vial puncture (9:57 AM and 4:11 PM). No reported symptoms.  No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2022-692952 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-692952:Same reporter